Patent · US Active

Predicting cancer outcome

US9534249B2 · kind B2 · utility

8Cited by

6References

4Claims

0Family size

Assignee

Mayo Foundation for Medical Education and Research · US

Inventors

George Vasmatzis · Byron, US
John C. Cheville · Pine Island, US
Farhad Kosari · Ellsworth, US
Cemile D. Savci-Heijink · Amsterdam, NL
Eric W. Klee · Rochester, US
Jan Marie A. Willard · Weslaco, US
Lori S. Tillmans · Stanton, US

Key dates

Filing date	Nov 30, 2012
Grant date	Jan 3, 2017
Priority date	—
Expiry date	Apr 9, 2033

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Q2600/16
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

This document provides methods and materials related to assessing prostate cancer in mammals. For example, this document provides nucleic acids and polypeptides that can be analyzed to determine whether a male mammal having prostate cancer is susceptible to a good or poor outcome.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.